Methods of treating pervasive development disorders
AssigneeCuremark, LLC
InventorJoan M. Fallon
Life of this patent
Estimating the term…
Abstract
A therapeutic method for treating an individual diagnosed with PDD pervasive developmental disorder comprises determining the efficacy of digestive enzyme administration for the treatment of the individual based on a measure of the individual's chymotrypsin level, and administering digestive enzymes to the individual based on the determination of the measure of the individual's chymotrypsin level. A method for reducing the amount of methylphenidate (Ritalin) being taken by an individual with attention deficit disorder (ADD) or attention deficit hyperactivity disorder (ADHD) by administering a therapeutic amount of digestive enzymes is also provided.
Claims10
A method for treating an individual with Attention Deficit Disorder (ADD) or Attention Deficit Hyperactivity disorder (ADHD) who is taking methylphenidate, the method comprising the steps of:
- measuring a level of chymotrypsin in a stool sample of the individual;
- administering digestive enzymes comprising proteases, lipases and amylases to the individual in an amount effective to promote protein digestion to improve a symptom of the disorder if the level of chymotrypsin in the stool sample indicates that the person suffers from a deficiency in protein digestion;
- monitoring a behavior of the individual;
- and
- adjusting the amount of methylphenidate being taken by the individual to an appropriate therapeutic level based on improvement in the behavior of the individual.
Dependencies are inferred from the claim text.